Home Healthcare IT Intravenous to Subcutaneous Drug Repositioning Market Size, Growth, 2033

Intravenous to Subcutaneous Drug Repositioning Market Size & Outlook, 2025-2033

Intravenous to Subcutaneous Drug Repositioning Market Size, Share & Trends Analysis Report By Product (Devices, Drugs), By Therapeutic (Cardiology, Oncology, Pulmonary arterial hypertension, Hematology, Others), By End-user (Hospitals and clinics, Research facilities, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRHI681DR
Last Updated : Jun, 2023
Pages : 110
Author : Debashree Bora
Format : PDF, Excel

Market Segmentation

  1. Intravenous to Subcutaneous Drug Repositioning Market, By Product (2021-2033)
    1. Devices
      1. Wearable SC injectors
      2. Wearable SC infusers
    2. Drugs
      1. Cancer drugs
      2. Blood factors
      3. Immunoglobulin G
      4. Antibiotics
      5. Remodulin
      6. Others
  2. Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic (2021-2033)
    1. Cardiology
    2. Oncology
    3. Pulmonary arterial hypertension
    4. Hematology
    5. Others
  3. Intravenous to Subcutaneous Drug Repositioning Market, By End-user (2021-2033)
    1. Hospitals and clinics
    2. Research facilities
    3. Others
    1. North America
      1. North America Intravenous to Subcutaneous Drug Repositioning Market, By Product
        1. Devices
          1. Wearable SC injectors
            1. Wearable SC infusers
            2. Drugs
              1. Cancer drugs
                1. Blood factors
                  1. Immunoglobulin G
                    1. Antibiotics
                      1. Remodulin
                        1. Others
                      2. North America Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                        1. Cardiology
                          1. Oncology
                            1. Pulmonary arterial hypertension
                              1. Hematology
                                1. Others
                                2. North America Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                  1. Hospitals and clinics
                                    1. Research facilities
                                      1. Others
                                      2. U.S.
                                        1. U.S. Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                          1. Devices
                                            1. Wearable SC injectors
                                              1. Wearable SC infusers
                                              2. Drugs
                                                1. Cancer drugs
                                                  1. Blood factors
                                                    1. Immunoglobulin G
                                                      1. Antibiotics
                                                        1. Remodulin
                                                          1. Others
                                                        2. U.S. Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                          1. Cardiology
                                                            1. Oncology
                                                              1. Pulmonary arterial hypertension
                                                                1. Hematology
                                                                  1. Others
                                                                  2. U.S. Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                    1. Hospitals and clinics
                                                                      1. Research facilities
                                                                        1. Others
                                                                      2. Canada
                                                                    2. Europe
                                                                      1. Europe Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                        1. Devices
                                                                          1. Wearable SC injectors
                                                                            1. Wearable SC infusers
                                                                            2. Drugs
                                                                              1. Cancer drugs
                                                                                1. Blood factors
                                                                                  1. Immunoglobulin G
                                                                                    1. Antibiotics
                                                                                      1. Remodulin
                                                                                        1. Others
                                                                                      2. Europe Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                        1. Cardiology
                                                                                          1. Oncology
                                                                                            1. Pulmonary arterial hypertension
                                                                                              1. Hematology
                                                                                                1. Others
                                                                                                2. Europe Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                  1. Hospitals and clinics
                                                                                                    1. Research facilities
                                                                                                      1. Others
                                                                                                      2. U.K.
                                                                                                        1. U.K. Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                          1. Devices
                                                                                                            1. Wearable SC injectors
                                                                                                              1. Wearable SC infusers
                                                                                                              2. Drugs
                                                                                                                1. Cancer drugs
                                                                                                                  1. Blood factors
                                                                                                                    1. Immunoglobulin G
                                                                                                                      1. Antibiotics
                                                                                                                        1. Remodulin
                                                                                                                          1. Others
                                                                                                                        2. U.K. Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                          1. Cardiology
                                                                                                                            1. Oncology
                                                                                                                              1. Pulmonary arterial hypertension
                                                                                                                                1. Hematology
                                                                                                                                  1. Others
                                                                                                                                  2. U.K. Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                    1. Hospitals and clinics
                                                                                                                                      1. Research facilities
                                                                                                                                        1. Others
                                                                                                                                      2. Germany
                                                                                                                                      3. France
                                                                                                                                      4. Spain
                                                                                                                                      5. Italy
                                                                                                                                      6. Russia
                                                                                                                                      7. Nordic
                                                                                                                                      8. Benelux
                                                                                                                                      9. Rest of Europe
                                                                                                                                    2. APAC
                                                                                                                                      1. APAC Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                        1. Devices
                                                                                                                                          1. Wearable SC injectors
                                                                                                                                            1. Wearable SC infusers
                                                                                                                                            2. Drugs
                                                                                                                                              1. Cancer drugs
                                                                                                                                                1. Blood factors
                                                                                                                                                  1. Immunoglobulin G
                                                                                                                                                    1. Antibiotics
                                                                                                                                                      1. Remodulin
                                                                                                                                                        1. Others
                                                                                                                                                      2. APAC Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                                                        1. Cardiology
                                                                                                                                                          1. Oncology
                                                                                                                                                            1. Pulmonary arterial hypertension
                                                                                                                                                              1. Hematology
                                                                                                                                                                1. Others
                                                                                                                                                                2. APAC Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                                                  1. Hospitals and clinics
                                                                                                                                                                    1. Research facilities
                                                                                                                                                                      1. Others
                                                                                                                                                                      2. China
                                                                                                                                                                        1. China Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                                                          1. Devices
                                                                                                                                                                            1. Wearable SC injectors
                                                                                                                                                                              1. Wearable SC infusers
                                                                                                                                                                              2. Drugs
                                                                                                                                                                                1. Cancer drugs
                                                                                                                                                                                  1. Blood factors
                                                                                                                                                                                    1. Immunoglobulin G
                                                                                                                                                                                      1. Antibiotics
                                                                                                                                                                                        1. Remodulin
                                                                                                                                                                                          1. Others
                                                                                                                                                                                        2. China Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                                                                                          1. Cardiology
                                                                                                                                                                                            1. Oncology
                                                                                                                                                                                              1. Pulmonary arterial hypertension
                                                                                                                                                                                                1. Hematology
                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                  2. China Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                                                                                    1. Hospitals and clinics
                                                                                                                                                                                                      1. Research facilities
                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                      2. Korea
                                                                                                                                                                                                      3. Japan
                                                                                                                                                                                                      4. India
                                                                                                                                                                                                      5. Australia
                                                                                                                                                                                                      6. Taiwan
                                                                                                                                                                                                      7. South East Asia
                                                                                                                                                                                                      8. Rest of Asia-Pacific
                                                                                                                                                                                                    2. Middle East and Africa
                                                                                                                                                                                                      1. Middle East and Africa Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                                                                                        1. Devices
                                                                                                                                                                                                          1. Wearable SC injectors
                                                                                                                                                                                                            1. Wearable SC infusers
                                                                                                                                                                                                            2. Drugs
                                                                                                                                                                                                              1. Cancer drugs
                                                                                                                                                                                                                1. Blood factors
                                                                                                                                                                                                                  1. Immunoglobulin G
                                                                                                                                                                                                                    1. Antibiotics
                                                                                                                                                                                                                      1. Remodulin
                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                      2. Middle East and Africa Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                                                                                                                        1. Cardiology
                                                                                                                                                                                                                          1. Oncology
                                                                                                                                                                                                                            1. Pulmonary arterial hypertension
                                                                                                                                                                                                                              1. Hematology
                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                2. Middle East and Africa Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                                                                                                                  1. Hospitals and clinics
                                                                                                                                                                                                                                    1. Research facilities
                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                      2. UAE
                                                                                                                                                                                                                                        1. UAE Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                                                                                                                          1. Devices
                                                                                                                                                                                                                                            1. Wearable SC injectors
                                                                                                                                                                                                                                              1. Wearable SC infusers
                                                                                                                                                                                                                                              2. Drugs
                                                                                                                                                                                                                                                1. Cancer drugs
                                                                                                                                                                                                                                                  1. Blood factors
                                                                                                                                                                                                                                                    1. Immunoglobulin G
                                                                                                                                                                                                                                                      1. Antibiotics
                                                                                                                                                                                                                                                        1. Remodulin
                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                        2. UAE Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                                                                                                                                                          1. Cardiology
                                                                                                                                                                                                                                                            1. Oncology
                                                                                                                                                                                                                                                              1. Pulmonary arterial hypertension
                                                                                                                                                                                                                                                                1. Hematology
                                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                                  2. UAE Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                                                                                                                                                    1. Hospitals and clinics
                                                                                                                                                                                                                                                                      1. Research facilities
                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                                      1. LATAM Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                                                                                                                                                        1. Devices
                                                                                                                                                                                                                                                                          1. Wearable SC injectors
                                                                                                                                                                                                                                                                            1. Wearable SC infusers
                                                                                                                                                                                                                                                                            2. Drugs
                                                                                                                                                                                                                                                                              1. Cancer drugs
                                                                                                                                                                                                                                                                                1. Blood factors
                                                                                                                                                                                                                                                                                  1. Immunoglobulin G
                                                                                                                                                                                                                                                                                    1. Antibiotics
                                                                                                                                                                                                                                                                                      1. Remodulin
                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                      2. LATAM Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                                                                                                                                                                                        1. Cardiology
                                                                                                                                                                                                                                                                                          1. Oncology
                                                                                                                                                                                                                                                                                            1. Pulmonary arterial hypertension
                                                                                                                                                                                                                                                                                              1. Hematology
                                                                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                                                                2. LATAM Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                                                                                                                                                                                  1. Hospitals and clinics
                                                                                                                                                                                                                                                                                                    1. Research facilities
                                                                                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                                                                                      2. Brazil
                                                                                                                                                                                                                                                                                                        1. Brazil Intravenous to Subcutaneous Drug Repositioning Market, By Product
                                                                                                                                                                                                                                                                                                          1. Devices
                                                                                                                                                                                                                                                                                                            1. Wearable SC injectors
                                                                                                                                                                                                                                                                                                              1. Wearable SC infusers
                                                                                                                                                                                                                                                                                                              2. Drugs
                                                                                                                                                                                                                                                                                                                1. Cancer drugs
                                                                                                                                                                                                                                                                                                                  1. Blood factors
                                                                                                                                                                                                                                                                                                                    1. Immunoglobulin G
                                                                                                                                                                                                                                                                                                                      1. Antibiotics
                                                                                                                                                                                                                                                                                                                        1. Remodulin
                                                                                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                                                                                        2. Brazil Intravenous to Subcutaneous Drug Repositioning Market, By Therapeutic
                                                                                                                                                                                                                                                                                                                          1. Cardiology
                                                                                                                                                                                                                                                                                                                            1. Oncology
                                                                                                                                                                                                                                                                                                                              1. Pulmonary arterial hypertension
                                                                                                                                                                                                                                                                                                                                1. Hematology
                                                                                                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                                                                                                  2. Brazil Intravenous to Subcutaneous Drug Repositioning Market, By End-user
                                                                                                                                                                                                                                                                                                                                    1. Hospitals and clinics
                                                                                                                                                                                                                                                                                                                                      1. Research facilities
                                                                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                                                                      2. Mexico
                                                                                                                                                                                                                                                                                                                                      3. Argentina
                                                                                                                                                                                                                                                                                                                                      4. Chile
                                                                                                                                                                                                                                                                                                                                      5. Colombia
                                                                                                                                                                                                                                                                                                                                      6. Rest of LATAM

                                                                                                                                                                                                                                                                                                                                  Available for purchase with detailed segment data, forecasts, and regional insights.

                                                                                                                                                                                                                                                                                                                                  Get This Report

                                                                                                                                                                                                                                                                                                                                  Download Free Sample

                                                                                                                                                                                                                                                                                                                                  Note: Please ensure you provide an active email address as we will be sending sample details via email.
                                                                                                                                                                                                                                                                                                                                  The button will be active once the above form is filled

                                                                                                                                                                                                                                                                                                                                  Our Clients:

                                                                                                                                                                                                                                                                                                                                  LG Electronics
                                                                                                                                                                                                                                                                                                                                  AMCAD Engineering
                                                                                                                                                                                                                                                                                                                                  KOBE STEEL LTD.
                                                                                                                                                                                                                                                                                                                                  Hindustan National Glass & Industries Limited
                                                                                                                                                                                                                                                                                                                                  Voith Group
                                                                                                                                                                                                                                                                                                                                  International Paper
                                                                                                                                                                                                                                                                                                                                  Hansol Paper
                                                                                                                                                                                                                                                                                                                                  Whirlpool Corporation
                                                                                                                                                                                                                                                                                                                                  Sony
                                                                                                                                                                                                                                                                                                                                  Samsung Electronics
                                                                                                                                                                                                                                                                                                                                  Qualcomm
                                                                                                                                                                                                                                                                                                                                  Google
                                                                                                                                                                                                                                                                                                                                  Fiserv
                                                                                                                                                                                                                                                                                                                                  Veto-Pharma
                                                                                                                                                                                                                                                                                                                                  Nippon Becton Dickinson
                                                                                                                                                                                                                                                                                                                                  Merck
                                                                                                                                                                                                                                                                                                                                  Argon Medical Devices
                                                                                                                                                                                                                                                                                                                                  Abbott
                                                                                                                                                                                                                                                                                                                                  Ajinomoto
                                                                                                                                                                                                                                                                                                                                  Denon
                                                                                                                                                                                                                                                                                                                                  Doosan
                                                                                                                                                                                                                                                                                                                                  Meiji Seika Kaisha Ltd
                                                                                                                                                                                                                                                                                                                                  LG Chemicals
                                                                                                                                                                                                                                                                                                                                  LCY chemical group
                                                                                                                                                                                                                                                                                                                                  Bayer
                                                                                                                                                                                                                                                                                                                                  Airrane
                                                                                                                                                                                                                                                                                                                                  BASF
                                                                                                                                                                                                                                                                                                                                  Toyota Industries
                                                                                                                                                                                                                                                                                                                                  Nissan Motors
                                                                                                                                                                                                                                                                                                                                  Neenah
                                                                                                                                                                                                                                                                                                                                  Mitsubishi
                                                                                                                                                                                                                                                                                                                                  Hyundai Motor Company

                                                                                                                                                                                                                                                                                                                                  We are featured on :

                                                                                                                                                                                                                                                                                                                                  Address:
                                                                                                                                                                                                                                                                                                                                  Office 515 A, Amanora Chambers,
                                                                                                                                                                                                                                                                                                                                  Amanora Park Town, Hadapsar,
                                                                                                                                                                                                                                                                                                                                  Pune 411028, Maharashtra, India.
                                                                                                                                                                                                                                                                                                                                  Contact Us:
                                                                                                                                                                                                                                                                                                                                  +1 646 905 0080 (U.S.)
                                                                                                                                                                                                                                                                                                                                  +91 8087085354 (India)
                                                                                                                                                                                                                                                                                                                                  +44 203 695 0070 (U.K.)

                                                                                                                                                                                                                                                                                                                                  sales@straitsresearch.com

                                                                                                                                                                                                                                                                                                                                  Quick Links
                                                                                                                                                                                                                                                                                                                                  Help
                                                                                                                                                                                                                                                                                                                                  Verified. Protected. Secure.
                                                                                                                                                                                                                                                                                                                                  DMCA.com Protection Status
                                                                                                                                                                                                                                                                                                                                  Secure Payments:
                                                                                                                                                                                                                                                                                                                                  Follow Us:
                                                                                                                                                                                                                                                                                                                                  www.straitsresearch.com © Copyright . All rights Reserved.